Correlation Between Mesoblast and Immunocore Holdings

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Mesoblast and Immunocore Holdings at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mesoblast and Immunocore Holdings into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Mesoblast and Immunocore Holdings, you can compare the effects of market volatilities on Mesoblast and Immunocore Holdings and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mesoblast with a short position of Immunocore Holdings. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mesoblast and Immunocore Holdings.

Diversification Opportunities for Mesoblast and Immunocore Holdings

-0.68
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Mesoblast and Immunocore is -0.68. Overlapping area represents the amount of risk that can be diversified away by holding Mesoblast and Immunocore Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Immunocore Holdings and Mesoblast is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mesoblast are associated (or correlated) with Immunocore Holdings. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Immunocore Holdings has no effect on the direction of Mesoblast i.e., Mesoblast and Immunocore Holdings go up and down completely randomly.

Pair Corralation between Mesoblast and Immunocore Holdings

Given the investment horizon of 90 days Mesoblast is expected to generate 3.26 times more return on investment than Immunocore Holdings. However, Mesoblast is 3.26 times more volatile than Immunocore Holdings. It trades about 0.2 of its potential returns per unit of risk. Immunocore Holdings is currently generating about -0.03 per unit of risk. If you would invest  858.00  in Mesoblast on October 25, 2024 and sell it today you would earn a total of  900.00  from holding Mesoblast or generate 104.9% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy96.61%
ValuesDaily Returns

Mesoblast  vs.  Immunocore Holdings

 Performance 
       Timeline  
Mesoblast 

Risk-Adjusted Performance

15 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Mesoblast are ranked lower than 15 (%) of all global equities and portfolios over the last 90 days. In spite of very inconsistent basic indicators, Mesoblast displayed solid returns over the last few months and may actually be approaching a breakup point.
Immunocore Holdings 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Immunocore Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable fundamental indicators, Immunocore Holdings is not utilizing all of its potentials. The current stock price agitation, may contribute to short-term losses for the retail investors.

Mesoblast and Immunocore Holdings Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Mesoblast and Immunocore Holdings

The main advantage of trading using opposite Mesoblast and Immunocore Holdings positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mesoblast position performs unexpectedly, Immunocore Holdings can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Immunocore Holdings will offset losses from the drop in Immunocore Holdings' long position.
The idea behind Mesoblast and Immunocore Holdings pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.

Other Complementary Tools

USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
CEOs Directory
Screen CEOs from public companies around the world
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes